Matrix Metalloproteinase Inhibition Attenuates Early Left Ventricular Enlargement After Experimental Myocardial Infarction in Mice
Authors:
- 15 June 1999
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 99 (23) , 3063-3070
Abstract
Background —Extracellular matrix synthesis and degradation contribute to the morphological changes that occur after myocardial infarction (MI). Methods and Results —We tested the hypothesis that inhibition of matrix metalloproteinases (MMPs) attenuates left ventricular remodeling in experimental MI. Seventy-one male FVB mice that survived ligation of the left anterior coronary artery were randomized to a broad-spectrum MMP inhibitor (CP-471,474) or placebo by gavage. Echocardiographic studies were performed before randomization (within 24 hours of surgery) and 4 days later and included short-axis imaging at the midpapillary and apical levels. Infarction as defined by wall motion abnormality was achieved in 79% of the procedures (n=56), and mortality rate during the 4-day protocol was 23% (9 of 36 on treatment vs 7 of 35 on placebo; P =NS). Baseline end-diastolic and end-systolic dimensions and areas were similar ( P =NS) between treated and placebo groups. At follow-up, infarcted mice allocated to MMP inhibitor had significantly smaller increases in end-systolic and end-diastolic dimensions and areas at both midpapillary and apical levels compared with infarcted mice allocated to placebo (all P P P Conclusions —–Administration of an MMP inhibitor attenuates early left ventricular dilation after experimental MI in mice. Further studies in genetically altered mice and other models will improve understanding of the role of MMPs in left ventricular remodeling.Keywords
This publication has 10 references indexed in Scilit:
- Assessment of regional left ventricular wall stress after myocardial infarction by echocardiography-based structural analysisJournal of the American Society of Echocardiography, 1998
- Metalloproteinase inhibitors and wound healing: A novel enhancer of wound strengthSurgery, 1998
- Increased Matrix Metalloproteinase Activity and Selective Upregulation in LV Myocardium From Patients With End-Stage Dilated CardiomyopathyCirculation, 1998
- Myocardial matrix metalloproteinase activity and abundance with congestive heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 1998
- Cloning of the gene for interstitial collagenase-3 (matrix metalloproteinase-13) from rabbit synovial fibroblasts: differential expression with collagenase-1 (matrix metalloproteinase-1)Biochemical Journal, 1998
- Echocardiographic and cardiac doppler assessment of miceJournal of the American Society of Echocardiography, 1995
- Regulation of collagen degradation in the rat myocardium after infarctionJournal of Molecular and Cellular Cardiology, 1995
- Ventricular Dilatation and Remodeling After Myocardial InfarctionMayo Clinic Proceedings, 1994
- Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing.Journal of Clinical Investigation, 1993
- Myocardial matrix metalloproteinase(s): localization and activationMolecular and Cellular Biochemistry, 1993